Some financial stocks look cheap because the market sees trouble coming. Others look cheap because investors are still nervous about last year’s credit cycle. This one looks closer to the second case.

Credit losses are improving, capital returns are getting bigger, tangible book value keeps growing, and the stock still trades at a single-digit earnings multiple.

Policy Tailwind Emerging (Sponsored)

The U.S. government pumped more than $1 billion into Intel.

The stock popped 128%. It pumped $400 million into MP Materials.

The stock popped 200%. It bought 10% of Trilogy Metals.

The stock popped 500%.

And now, Trump has chosen this AI stock for a $1 billion payday.

Click here for the full story and stock pick (free).

*This ad is sent on behalf of InvestorPlace Media at 1125 N. Charles Street, Baltimore, Maryland 21201. If you're not interested in this opportunity, please click here.

What Just Happened

The quarter beat on earnings

Synchrony Financial (NYSE: SYF) reported first-quarter 2026 EPS of $2.27, ahead of the $2.20 estimate. Net earnings were $805 million, up from $757 million a year earlier, and EPS rose 20% from $1.89 last year. That is a clean result for a stock trading around 7.5x forward earnings. 

Credit trends improved

The most important part of the quarter was credit quality. Net charge-offs fell to 5.42% of average loan receivables from 6.38% a year earlier, a 96-basis-point improvement. Loans 90+ days past due were also slightly lower year over year, and allowance coverage stood at 10.42%. For a consumer lender, that matters more than a flashy headline. 

Capital returns got louder

Synchrony returned about $1.0 billion to shareholders in Q1, including $900 million of share repurchases and $104 million of common dividends. The board also approved a new $6.5 billion share repurchase program and plans to raise the quarterly dividend by 13% to $0.34 starting in Q3. That is a strong capital-return signal.

Why The Business Matters

This is a partner-driven credit platform

Synchrony powers credit cards, installment loans, banking products, and financing programs through major partners across retail, healthcare, digital platforms, and services. The company supports more than 73 million active accounts and works with brands like Amazon, PayPal, Lowe’s, and healthcare financing platform CareCredit.

The partnership network is the moat

Synchrony’s model is built around being embedded inside commerce and care decisions. That makes the company more than a generic credit-card lender. It is a financing layer for retailers, healthcare providers, and digital platforms that want to offer payment flexibility without building the credit infrastructure themselves.

CareCredit keeps expanding

In February, Synchrony expanded its Planet DDS partnership by integrating CareCredit across Planet DDS platforms, including more than 2,500 Cloud 9 orthodontic practices and over 15,000 Denticon dental practices. That strengthens Synchrony’s healthcare-financing channel and gives CareCredit more reach inside dental workflows. 

Try AI Free (Sponsored)

First users could have already grown their money dramatically every single year this AI has been running, based on the average winning trades it uncovers – WITHOUT following market news, WITHOUT watching central banks, and WITHOUT the stress most traders deal with daily.

For a limited time, you can try this AI yourself, completely free – no email, no credit card needed

Why The Stock Has A Case

EPS growth has been excellent

You flagged that Synchrony’s EPS has grown 37.9% annually over the last two years, massively outpacing peers. Q1 added to that story with EPS up 20% year over year. That is not the kind of earnings profile that usually sits at 7.5x forward earnings unless investors are still pricing in credit stress.

Tangible book value keeps compounding

Tangible book value per share increased 8% year over year to $37.62 in Q1, while book value per share rose 12% to $45.29. You also noted that tangible book value per share has grown 15.9% annually over the last five years. That is one of the cleanest signals of value creation in financials. 

Returns are strong

Synchrony produced a 2.7% return on average assets and a 24.5% return on tangible common equity in Q1. Those are excellent returns for a financial company, especially one trading at a discounted multiple. 

The valuation is the hook

At roughly 7.5x forward earnings, SYF is priced like investors still expect a lot to go wrong. But credit trends are improving, buybacks are aggressive, and capital ratios remain healthy, with CET1 at 12.7% and total risk-based capital at 16.0%. That combination makes the stock look too cheap. 

Elite Trade Club Insider

$326 Million In Insider Supply Just Hit Two Market Winners

A major holder sold $52.8 million worth of stock in a digital advertising name near its 52-week high, while investment entities tied to a tech hardware giant filed proposed sales worth more than $273 million after a 331% one-year run. You’re seeing two stocks that already moved. Insider readers are seeing where big holders are using momentum to turn paper gains into cash.

You’re reading the free version. Here’s what we held back.

Every day, insiders and institutions move millions before the market catches on. We surface the data behind those moves before the rest of the market sees it.

A subscription gets you:

  • The insider buys, options bets, and dark pool moves the free edition can't show you. Unlocked every weekday.

  • A Sunday Deep Dive that tells you where to look before Monday's bell rings.

  • The Friday Smart Money Brief: who bought, who sold, where the big options bets landed, and where institutions are hiding volume. Three data layers. One email.

  • A Monthly Insider Scorecard so you always know whether smart money is buying or selling the market.

  • Every past Insider edition, unlocked, on elitetrade.club. Go back and see what you missed.

$25/mo or $250/yr. 30-day money back guarantee. Cancel anytime. Founding member pricing: lock in $25/mo before we raise it.

What Has To Go Right

Credit losses need to stay under control

Management expects net charge-offs to remain below 5.5% for the full year, with losses peaking seasonally in Q2. If that holds, the market should get more comfortable with the earnings base. 

Loan receivables need to grow

Synchrony expects mid-single-digit ending loan receivables growth by year-end, supported in part by roughly $725 million of Lowe’s commercial co-brand receivables onboarding. That growth needs to show up without forcing the company to lower credit standards. 

Buybacks need to keep reducing the share count

The $6.5 billion repurchase authorization is large relative to the company’s market cap. If Synchrony keeps buying stock at a single-digit multiple while credit remains stable, per-share earnings and tangible book value should keep improving.

What Elon Said (Sponsored)

I recently paid $5,000 to be in a room with Elon Musk in Los Angeles.

And what he said in that room, confirmed everything my 15+ years in the tech industry had been telling me.

I believe what Elon is launching right now — a project 27 years in the making — could be his biggest move yet.

If you buy just one stock in 2026, I urge you to make it the one I'm giving away for free here.

*This ad is sent on behalf of InvestorPlace Media at 1125 N. Charles Street, Baltimore, Maryland 21201. If you're not interested in this opportunity, please click here.

What Could Trip It Up

Consumer credit can turn quickly

This is the main risk. Synchrony lends to consumers, and credit quality can deteriorate if unemployment rises, wages weaken, or lower-income households come under pressure. A few quarters of higher delinquencies would hit the stock quickly.

The business is sensitive to funding costs

Net interest margin improved to 15.50% in Q1, up 76 basis points year over year, helped by loan yields and lower interest expense. If funding costs rise again or deposit competition heats up, margin improvement gets harder. 

Partner concentration always matters

Big partnerships are a strength, but they are also a risk. Synchrony depends on major partner relationships to keep driving account growth, purchase volume, and receivables. Losing or repricing a major relationship can pressure growth and sentiment.

What I’d Watch Next

The first thing to watch is net charge-offs. If they remain below the 5.5% full-year target, the bull case gets stronger. The second is loan receivables growth, especially whether new volume comes in without weaker credit quality.

The third is capital returns, because the new buyback can materially improve per-share metrics. The fourth is tangible book value per share, which remains one of the best scorecards for this stock.

My Take

Buy at current levels. Synchrony has strong EPS growth, excellent returns on tangible equity, improving credit quality, a growing tangible book value base, and a major buyback program. At roughly 7.5x forward earnings, the stock is too cheap for the current numbers.

The key risk is consumer credit. If charge-offs reaccelerate or delinquencies rise, the market will keep the stock at a low multiple. But with Q1 credit metrics improving and management guiding to net charge-offs below 5.5% this year, the risk-reward favors buying here.

Action Recap

💳 Looking to buy? Buy at current levels for a low-multiple financial with improving credit trends and strong capital returns.

📈 Already own it? Keep holding. EPS growth, tangible book value growth, and buybacks support more upside.

⚠️ Main risk to respect: Consumer credit is the swing factor. If charge-offs rise again, the stock gets punished fast.

The key risk is consumer credit. If charge-offs reaccelerate or delinquencies rise, the market will keep the stock at a low multiple. But with Q1 credit metrics improving and management guiding to net charge-offs below 5.5% this year, the risk-reward favors buying here.

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.

Keep Reading